# PatientPing

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/patientping

- Industry: Software
- Headquarters: Boston, US
- Website: www.patientping.com
- Total disclosed funding: $98M
- Latest round: Series C (Feb 21, 2019)
- Investors on record: 6

## About

PatientPing, Inc. enhances healthcare coordination with its innovative Real-Time Care Intelligence™ platform, which facilitates timely access to care and streamlines referrals for behavioral health services across various healthcare settings.Founded in 2013, PatientPing, Inc. is based in Boston, US, and specializes in connecting patients with behavioral health challenges to personalized interventions. The company has received significant funding, including an Add-on, Trade Sale round in March 2021 amounting to USD 500.00 mn, with a total amount raised of USD 56.50 mn. Jay Desai serves as both CEO and founder of the company, and it has completed 4 deals to date.Bamboo Health, the parent company of PatientPing, Inc., is a leading provider of Real-Time Care Intelligence™, focusing on solutions for behavioral health care complexities. Its core product, Bamboo Bridge, integrates care navigators and a nationwide insights network to enhance patient access to timely care and overall mental health services. The platform serves over 2,500 hospitals, 8,000 post-acute facilities, 25,000 pharmacies, and 32 health plans, targeting a wide range of healthcare providers and state governments across the United States.Bamboo Health generates revenue through subscription-based models and partnerships with healthcare organizations. Its Bamboo Bridge platform operates on a subscription model, allowing clients access to real-time insights and care coordination features. These transactions occur between the company and its healthcare providers and payers, enabling improved care outcomes and facilitating scalable implementation across various healthcare settings.Following its acquisition by Appriss Inc. on March 23, 2021, for USD 500 mn, PatientPing, Inc. plans to enhance its software and analytics solutions across the continuum of physical and behavioral health. The additional resources from this acquisition will support the launch of upcoming products and facilitate expansion into new geographic markets. Specific regions targeted for growth and product releases are expected to be outlined in the coming fiscal year, focusing on integrating their solutions to further streamline care transitions and improve patient outcomes.

## Funding rounds

- Series C, Feb 21, 2019, $57M — F-Prime Capital, GV, Andreessen Horowitz, Transformation Capital
- Series B, Nov 23, 2016, $32M — Andreessen Horowitz, Transformation Capital
- Series A, May 6, 2015, $9.7M — First Round Capital, F-Prime Capital, GV, SV Angel

## Investors

- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Series A
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series C
- GV (https://capitalatlas.ai/funds/gv) — Series A, Series C
- SV Angel (https://capitalatlas.ai/funds/sv-angel) — Series A
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series B, Series C
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series B, Series C